Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert W Baker

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Chemical Communications (Cambridge, England)|August 12, 2021
Selective delivery of remarkably high levels of gadolinium to tumour cells using an arsonium saltMadeline S A Windsor, Madleen Busse, Daniel E Morrison, et al.
International Journal of Geriatric Psychiatry|October 27, 2005
Olanzapine does not enhance cognition in non-agitated and non-psychotic patients with mild to moderate Alzheimer's dementiaJohn Kennedy, Walter Deberdt, Alan Siegal, et al.
Bipolar Disorders|March 27, 2003
Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar maniaK N Roy Chengappa, Robert W Baker, Lixin Shao, et al.
Schizophrenia Research|April 22, 2004
An excitement subscale of the Positive and Negative Syndrome ScaleJean-Pierre Lindenmayer, Eileen Brown, Robert W Baker, et al.
The Journal of Clinical Psychiatry|January 2, 2007
Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trialRoy H Perlis, Robert W Baker, Carlos A Zarate, et al.
Bipolar Disorders|January 19, 2005
Recovery and functional outcomes following olanzapine treatment for bipolar I maniaK N Roy Chengappa, John Hennen, Ross J Baldessarini, et al.
Journal of Clinical Psychopharmacology|March 18, 2003
Acute dysphoric mania: treatment response to olanzapine versus placeboRobert W Baker, Mauricio Tohen, Jan Fawcett, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 2, 2004
Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric maniaRobert W Baker, Eileen Brown, Hagop S Akiskal, et al.
The American Journal of Psychiatry|February 2, 2006
Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapineMauricio Tohen, Joseph R Calabrese, Gary S Sachs, et al.
The American Journal of Psychiatry|July 2, 2003
Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week studyMauricio Tohen, Terence A Ketter, Carlos A Zarate, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Chemical Communications (Cambridge, England)|August 12, 2021
Selective delivery of remarkably high levels of gadolinium to tumour cells using an arsonium saltMadeline S A Windsor, Madleen Busse, Daniel E Morrison, et al.
International Journal of Geriatric Psychiatry|October 27, 2005
Olanzapine does not enhance cognition in non-agitated and non-psychotic patients with mild to moderate Alzheimer's dementiaJohn Kennedy, Walter Deberdt, Alan Siegal, et al.
Bipolar Disorders|March 27, 2003
Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar maniaK N Roy Chengappa, Robert W Baker, Lixin Shao, et al.
Schizophrenia Research|April 22, 2004
An excitement subscale of the Positive and Negative Syndrome ScaleJean-Pierre Lindenmayer, Eileen Brown, Robert W Baker, et al.
The Journal of Clinical Psychiatry|January 2, 2007
Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trialRoy H Perlis, Robert W Baker, Carlos A Zarate, et al.
Bipolar Disorders|January 19, 2005
Recovery and functional outcomes following olanzapine treatment for bipolar I maniaK N Roy Chengappa, John Hennen, Ross J Baldessarini, et al.
Journal of Clinical Psychopharmacology|March 18, 2003
Acute dysphoric mania: treatment response to olanzapine versus placeboRobert W Baker, Mauricio Tohen, Jan Fawcett, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 2, 2004
Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric maniaRobert W Baker, Eileen Brown, Hagop S Akiskal, et al.
The American Journal of Psychiatry|February 2, 2006
Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapineMauricio Tohen, Joseph R Calabrese, Gary S Sachs, et al.
The American Journal of Psychiatry|July 2, 2003
Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week studyMauricio Tohen, Terence A Ketter, Carlos A Zarate, et al.
Pageof 4